Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.09%, DAX +0.02%, CAC (0.06%)

Apr 04 ,2024

  • Synopsis

    • European equity markets are set to open flat amidst Asian equities higher Thursday. Markets in Japan, Korea and Australia all logging gains as S&P 500 futures advance afterhours. Greater China markets closed for Qinming Festival/Tomb Sweeping Day. Dollar steady after retreating following ISM services. Copper leading commodity market gains. Gold holding near record high while crude little changed near late-Oct 2023 high. Bitcoin range bound.

    • On today's agenda, EU's Vestager, Dombrovskis and Breton participate in a fireside chat in the margins of the 6th Ministerial Meeting of the EU-US Trade and Technology Council meeting. EU's Jourová speaks at the conf 'Czechia in the EU: Next 20 years' and EU's Simson in Sydney (though Fri) and delivers a speech at the roundtable discussion event of the European Australian Business Council. In addition, discussion at 15:00BST on European reinsurers (Fitch Ratings)

    • In central banks updates, Riksbanks MPC meeting minutes at 9:30CET. ECB MPC meeting minutes at 13:30CET, the same time as Riksbank's Bunge speaks at a seminar organised by the Swedish Corporate Institute and OECD. Italy Central Bank co-hosts event (through Fri) title Financial Stability and Regulation.

    • Macroeconomic releases include: Italy, Spain Mar services PMIs with final reads for Eurozone, France, Germany and UK, Switzerland Mar CPI, Spain Mar unemployment change, Eurozone Feb PPI and Ireland Mar unemployment rate.

    • In corporate news, Solutions 30 (S30.FP) and Synergie (SDG.FP) both released their respective FY earnings yesterday after the EU close. In the DACH region, GRENKE (GLJ.GR) reported this morning a trading update for Q1 including new leasing business of €669.8M vs year-ago €610.2M. lastminute.com (LMN.SW) posted final FY earnings in line with preliminary release.

    • On M&A front, Compagnie de Saint-Gobain (SGO.FP) announced yesterday after the close the signing a definitive agreement to acquire the Bailey Group Companies for ~ €600M in cash. In corporate events, HENSOLDT (HAG.GR) hosting conf call today at 14:00 CEST on its completed acquisition of ESG Elektroniksystem- und Logistik-GmbH.

    • In other corporate developments, Saab's (SAAB.B.SS) CFO and Deputy CEO Christian Luiga to leave the company in order to pursue a new opportunity at a global company in a different industry segment.

  • Politics/Macro

    • How Europe lost faith in the power of EU-US trade talks - FT

    • NATO ministers' doubts, fears and eye-rolls over €100B Ukraine plan - Politico

    • Gold continues record rally after Fed comments - Reuters

    • Switzerland Is Reworking Its Rulebook to Stop Another Banking Meltdown - Bloomberg

  • Top company news

    • Earnings/updates

      • CYAD.BB (Celyad Oncology) -- reports FY net income (€8.5M) vs year-ago (€40.9M)

      • RDC.GR (Redcare Pharmacy) -- reports preliminary Q1 revenue €560M vs year-ago €372M

      • S30.FP (Solutions 30) -- reports FY net income (€22.7M) vs year-ago (€50.1M)

      • SDG.FP (Synergie) -- reports FY net income €78.6M vs year-ago €88.2M

      • LMN.SW (lastminute.com) -- reports final FY earnings in line with prelim. release; net income attributable €7.0M vs FactSet €3.9M [1 est]

      • GLJ.GR (GRENKE) -- reports Q1 new leasing business of €669.8M vs year-ago €610.2M

      • ALMDG.FP (MGI Digital Graphic Technology) -- reports FY net income €8.2M vs FactSet €7.5M [1 est]

    • M&A

      • OR.FP (L'Oreal) -- exploring purchase of minority stake in Amouage - Bloomberg

      • RF.FP (Eurazeo) -- completes the sale of Dutch Ophthalmic Research Center to Carl Zeiss Meditec

      • SGO.FP (Compagnie de Saint-Gobain) -- signs a definitive agreement to acquire the Bailey Group Companies for ~ €600M in cash

      • DEMANT.DC (Demant) -- ACCC will not oppose revised Cochlear, Oticon Medical transaction

      • SRG.IM (Snam) -- exercises its pre-emptive right to increase from 7.3% to 30%, its stake in Adriatic LNG regasification terminal

      • APPS.SM (Applus Services) -- releases its board's reports on offers by Amber EquityCo and Manzana Spain Bidco's

      • US.IM (UnipolSai Assicurazioni) -- UnipolSai Assicurazioni's board deemed fair, from a financial point of view, the €2.70/share cum dividend offer from Unipol Gruppo

      • MTW.LN (Mattioli Woods) -- completes acquisition of Newable Ventures Limited by Maven Capital Partners UK

    • Healthcare

      • SAN.FP (Sanofi) -- reportedly settles Zantac cases in 5 states - Bloomberg

      • UCB.BB (UCB) -- UCB's supplemental Biologics License Applications for BIMZELX (bimekizumab-bkzx) for moderate to severe hidradenitis suppurativa and additional 2ML device presentations accepted by FDA

      • BSLN.SW (Basilea Pharmaceutica) -- FDA grants approval of Zevtera to Basilea Pharmaceutica for the treatment of adults with Staphylococcus aureus bloodstream infections

      • AB.FP (AB Science) -- announces that Health Canada has granted eligibility for reconsideration request for masitinib in amyotrophic lateral sclerosis

      • MED.SW (Medartis Holding) -- launches senior convertible bond offering via accelerated bookbuild through BofA

      • BSLN.SW (Basilea Pharmaceutica) -- confirms FDA granted approval of Zevtera for three indications

    • Other

      • TIT.IM (Telecom Italia) -- Rome Court of Appeal has settled in favor of Telecom Italia a 15-year dispute concerning the restitution of the license fee claimed for 1998

      • VK.FP (Vallourec) -- enters partnership with Maire Tecnimont's NextChem for hydrogen storage

      • ABDN.LN (abrdn Plc) -- Proxy adviser Glass Lewis urges abrdn shareholders to vote against remuneration report, criticising incoming CFO's salary - FT

      • SOLB.BB (Solvay) -- mentioned positively by Greenlight Capital's David Einhorn at Sohn Conference

      • DNO.NO (DNO ASA) -- DNO Kurdistan Operations Recover Rapidly from Torrential Flooding

      • MED.SW (Medartis Holding) -- successfully places CHF115.8M convertible bonds due 2031

  • Key rating changes

    • Upgrades

      • LLOY.LN (Lloyds Banking Goup) -- to outperform from market perform at Keefe, Bruyette & Woods

      • NWG.LN (NatWest Group) - to market perform from underperform at Keefe, Bruyette & Woods

      • PAGE.LN (PageGroup) -- to buy from neutral at UBS

      • PST.IM (Poste Italiane) -- to buy from neutral at UBS

      • EDV.GR (CTS Eventim) -- to buy from hold at Kepler Cheuvreux

    • Downgrades

      • RACE.IM (Ferrari) -- to equal weight from overweight at Barclays

      • HOLN.SW (Holcim) -- to hold from buy at HSBC

      • ARJO.B.SS (Arjo) -- Arjo long-term recommendation downgraded to market perform from outperform at Handelsbanken

      • GIVN.SW (Givaudan) -- to reduce from add at Baader Helvea

    • Other Actions

      • PINE.LN (Pinewood Technologies Group) -- resumed buy at Jefferies

  • Data

    • Nikkei +1.00% to 39845.68

    • Hang Seng +0.00% to 16725.10

    • Shanghai Composite +0.00% to 3069.30

    • S&P futures +11.3 vs prior close of 5266.5

    • €-$ +0.0013 or +0.12% to 1.0847

    • $-¥ (0.02) or (0.01%) to 151.66

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE